Drug names - A random choice or a placebo effect
DOI:
https://doi.org/10.32385/rpmgf.v23i1.10324Keywords:
Drugs, Placebo effect, Brand names, EthicsAbstract
Introduction: The choice of a drug trade name is not a naïve choice, several parameters rules theattribution of the new drugs names. Brand names can raise important ethical issues. Objectives: This study had as main objective to analyze the Portuguese market drugs trade names. Methodology: All the drugs registered on the Therapeutic National Index were analysed, correspondingto 1.315 drugs trade names, belonging to 12 therapeutic groups. Results: In general, 26% of the drugs names were classified names attributed in agreement withthe active substance chemical name; in 26% of the cases, the name was based on the drugs indicationsor action, being this classification type associated with the chemical name in 4% andwith the name of the producing laboratory in 1%. Forty per cent of the analyzed drugs had namesconsidered opaque. The type of attributed name varied according with the therapeutic group. Discussion and Conclusions: It is possible to affirm that a high percentage of the Portuguese drugshave trade names that evoke some suggestion type, being this suggestion direct to the final consumer,to the health professionals or just an assertive type of information.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.